Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease

To measure exclusion of elderly adults from randomized trials studying drug interventions for ischemic heart disease (IHD) and describe the characteristics of these trials.

[1]  H. Bøtker,et al.  Thirty‐year trends in heart failure hospitalization and mortality rates and the prognostic impact of co‐morbidity: a Danish nationwide cohort study , 2016, European journal of heart failure.

[2]  R. Giugliano,et al.  Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non–ST-Segment–Elevation Acute Coronary Syndromes Clinical Trials , 2016, Circulation.

[3]  Y. Juillière,et al.  National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000–2012 , 2015, European journal of heart failure.

[4]  A. Jaffe,et al.  Acute coronary syndromes in the community. , 2015, Mayo Clinic proceedings.

[5]  G. Onder,et al.  Treating heart failure in older and oldest old patients. , 2015, Current pharmaceutical design.

[6]  T. Jernberg,et al.  Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients , 2015, JACC. Heart failure.

[7]  H. Cloft,et al.  Hospitalization Costs for Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention in the United States Are Substantially Higher Than Medicare Payments , 2015, Clinical cardiology.

[8]  Jonathan H Seltzer,et al.  Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines. , 2014, JAMA internal medicine.

[9]  Micah B. Hartman,et al.  US health spending trends by age and gender: selected years 2002-10. , 2014, Health affairs.

[10]  C. Murray,et al.  The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study , 2014, Circulation.

[11]  Richard Coles,et al.  Summary health statistics for U.S. adults: national health interview survey, 2012. , 2014, Vital and health statistics. Series 10, Data from the National Health Survey.

[12]  V. Roger,et al.  Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study. , 2013, American journal of epidemiology.

[13]  C. O'connor,et al.  Heart failure in elderly patients: distinctive features and unresolved issues , 2013, European journal of heart failure.

[14]  A. Cruz-Jentoft,et al.  Exclusion of Older Adults from Ongoing Clinical Trials About Type 2 Diabetes Mellitus , 2013, Journal of the American Geriatrics Society.

[15]  N. Leighl,et al.  Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC? , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  L. Trinquart,et al.  Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs , 2012, PloS one.

[17]  H. Krumholz,et al.  Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis , 2012, BMJ : British Medical Journal.

[18]  Antonio Cherubini,et al.  The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. , 2011, Archives of internal medicine.

[19]  M. Rich,et al.  Age disparities in heart failure research. , 2010, JAMA.

[20]  Kenneth D. Mandl,et al.  Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov , 2010, Annals of Internal Medicine.

[21]  P. Austin,et al.  Secular trends in acute coronary syndrome hospitalization from 1994 to 2005. , 2010, The Canadian journal of cardiology.

[22]  B. Yawn,et al.  Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction , 2010, Circulation.

[23]  J. Ioannidis,et al.  The elderly were under-represented in osteoarthritis clinical trials. , 2009, Journal of clinical epidemiology.

[24]  E. Larson,et al.  Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin IIReceptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults? , 2009, Annals of Internal Medicine.

[25]  Cameron Rhudy,et al.  How Congress May Have Failed Consumers with the Food and Drug Administration Amendments Act of 2007 , 2008 .

[26]  A. Kiss,et al.  Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. , 2007, JAMA.

[27]  Peter E. Rossi,et al.  Bayesian Statistics and Marketing , 2005 .

[28]  J. Ioannidis,et al.  Why Most Published Research Findings Are False , 2005, PLoS medicine.

[29]  P. Dieppe,et al.  Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs , 2004, BMJ : British Medical Journal.

[30]  Jeannine S. Schiller,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2002. , 2004, Vital and health statistics. Series 10, Data from the National Health Survey.

[31]  Harlan M Krumholz,et al.  Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.

[32]  W. Tadd,et al.  Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study , 2000, BMJ : British Medical Journal.

[33]  F. Cavalli,et al.  Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  C. Coltman,et al.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.

[35]  G. Bugeja,et al.  Exclusion of elderly people from clinical research: a descriptive study of published reports , 1997, BMJ.

[36]  Humphrey D L Birley,et al.  Implicit memory , 1994, BMJ.

[37]  A. Cohen,et al.  Estimating the Mean and Variance of Normal Populations from Singly Truncated and Doubly Truncated Samples , 1950 .

[38]  B. Gersh,et al.  Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction , 2011 .

[39]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[40]  B. Gersh.  Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction , 2011 .

[41]  Karen Shashok,et al.  BMC Medical Research Methodology BioMed Central Debate Conducting a meta-ethnography of qualitative literature: Lessons learnt , 2008 .

[42]  R. Horton,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, Circulation.